Adults with obesity using a GLP-1 have a similar risk for obesity-related cancers as those who undergo bariatric surgery, researchers reported in data presented at the European Congress on Obesity and ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

A one-unit increase in cholangioscopy procedures was linked to a 24% increase in subsequent cholangiocarcinoma diagnoses the ...

Creators of the OpenEvidence AI data aggregation tool have partnered with the New England Journal of Medicine to provide 35 ...

On Thursday, the “Make America Healthy Again” commission released its first report on the potential contributors of chronic ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

A subretinal injection of ATSN-201 gene therapy demonstrated promising results in patients with X-linked retinoschisis in a ...

The National Kidney Foundation Council of Advanced Practice Providers conducts an online survey every 2 years to assess changes in the workforce and utilization of advanced practice providers in ...

It is a challenging time to be a women’s health care provider, but there are ways physicians can reclaim their power while ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

A machine learning model may be reliable for determining risk for postpartum depression, underscoring the need for greater ...